PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1182891
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1182891
The Photoacoustic Imaging Market size was valued at USD 130.8 Million in 2021, expanding at a CAGR of 20.8% from 2022 to 2028.
In the field of medical imaging, photoacoustic imaging is a new hybrid imaging modality that offers multi-contrast, multiscale imaging and biological characteristics ranging from organelles to whole organs. Photoacoustic imaging uses a variety of products, including imaging equipment, contrast materials, and software, among others.
Over the forecast period, it is anticipated that the application in research and development activities will grow, driving up product demand. Recently, a lot of researchers have focused on researching deep tissues to use PAI for clinical diagnosis and treatment. For instance, a new contrast agent for deep tissue PAI was introduced by Prof. Chulhong Kim of Creative IT Engineering at POSTECH and his students. They employed a nickel-based nanoparticle that absorbs light at a wavelength of 1,064 nm as a contrast agent. In contrast to earlier research, scientists were able to capture photos of live animal tissues that had been pierced to a maximum depth of 3.4 cm-this is the deepest image ever captured utilizing this wavelength.
The Global Photoacoustic Imaging Market is segmented based on Product, Type, Application, and Region.
Based on product, the market is divided into Photoacoustic Tomography and Photoacoustic Microscopy. The Photoacoustic Tomography segment is expected to dominate the market during the forecast period. With the fewest real-world restrictions on image performance, PAT is the most flexible and open-ended photoacoustic imaging approach. In terms of spatial resolution, frame rates, and detection sensitivity, PAT technology has evolved significantly. The use of PAT in fundamental biological sciences has significantly increased, and numerous clinical applications have been suggested.
Based on the application, the market is segmented into oncology, cardiology, angiology, histology, and interventional radiology. The oncology segment is expected to capture the largest market share during the forecast period. An important clinical use for PAI in oncology is breast cancer imaging. In terms of clinical application, breast imaging is the most advanced PAI technology. Its advantages include oxygen saturation mapping and non-contrast imaging of the neovasculature around tumors.
Regionally, North America is expected to dominate the market during the forecast period. The region's huge number of market competitors, as well as the rising number of cancer patients, appear to be factors contributing to regional market growth. According to the National Cancer Institute, an estimated 1,806,590 new cases of cancer would be diagnosed in the United States year 2020. Furthermore, increased funding has bolstered the region's research activities. The United States spends the most per person on healthcare and has the highest research funds and grants accessible through government bodies such as the National Institutes of Health (NIH).
In October 2021, the New inVision TRIO preclinical optoacoustic imaging system has been released, according to iThera Medical. The inVision TRIO is the first imaging system in the world to offer transmission ultrasonic computed tomography (TUCT), expanding the scope of biomedical applications supported by the optoacoustic imaging systems provided by iThera Medical.
In October 2020, Advantest Corporation developed a dual-wavelength laser for its HadatomoZ photoacoustic microscope. This allows for three-dimensional imaging of melanin and vascular networks in the skin.
The scope of this report covers the market by its major segments, which include as follows: